학술논문

Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up
Document Type
Article
Source
In: Journal of Neuroimmunology. (Journal of Neuroimmunology, 15 October 2015, 287:64-70)
Subject
Language
English
ISSN
18728421
01655728